Eric Rose

Eric Rose

Technik-/Wissenschafts-/F&E-Leiter bei MESOBLAST LIMITED

Vermögen: 10 Mio $ am 31.05.2026

75 Jahre
Health Technology
Finance
Consumer Services

Profil

Eric A. Rose is the founder of VTVX Holdings I LLC.
Current positions include Chairman at LongView Ventures LLC, Executive Director & Chief Medical Officer at Mesoblast Ltd. since 2022, Director at Orchestra BioMed, Inc. since 2018, Advisor at KBL Healthcare Ventures, and Executive Vice President-Life Sciences at MacAndrews & Forbes LLC since 2007.
Former roles include Chairman at SIGA Technologies, Inc. from 2018 to 2021, Chairman-Surgery Department at NewYork-Presbyterian Hospital from 1994 to 2007, Chairman-Health Evidence & Policy Department at Icahn School of Medicine at Mount Sinai from 2008 to 2012, Chairman-Surgery Department at Columbia University College of Physicians & Surgeons from 1994 to 2007, Independent Director at ABIOMED, Inc. from 2014 to 2022, Director at Nexell Therapeutics, Inc., Director at Keryx Biopharmaceuticals, Inc., Director at Nephros, Inc. from 1997 to 2009, Director at CircuLite, Inc., Director at Cambrex High Point, Inc., Director at National Preparedness & Response Science Board in 2011, Independent Non-Executive Director at Orchestra Biomed Holdings, Inc. from 2023 to 2025, President at International Society for Heart & Lung Transplantation, Executive Vice President-Life Sciences at MacAndrews & Forbes Inc., and member of the Strategic Advisory Board at Broadview Ventures Inc. Education includes undergraduate and doctorate degrees from Columbia University College of Physicians & Surgeons.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.03.2026 6.749.274 ( 0,52 % ) 10 Mio $ 31.05.2026

Aktive Positionen von Eric Rose

UnternehmenPositionBeginn
MESOBLAST LIMITED Technik-/Wissenschafts-/F&E-Leiter 01.02.2022
Vorsitzender -
Direktor/Vorstandsmitglied 01.12.2018
Corporate Officer/Principal 01.01.2007
Berater -

Ehemalige bekannte Positionen von Eric Rose

UnternehmenPositionEnde
ORCHESTRA BIOMED HOLDINGS, INC. Direktor/Vorstandsmitglied 03.02.2025
ABIOMED, INC. Direktor/Vorstandsmitglied 22.12.2022
SIGA TECHNOLOGIES, INC. Vorstandsvorsitzender 13.10.2016
Corporate Officer/Principal 01.01.2012
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Eric Rose im Detail an

Ausbildung von Eric Rose

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

61

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Distribution Services

International Society for Heart & Lung Transplantation

Health Services

Finance

Finance

Health Technology

Consumer Services

Finance

Finance

Consumer Services

National Preparedness & Response Science Board

Health Technology

Health Technology

Finance

Health Technology

-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT